Sharekhan

Data is delayed. Analysis is best done in real-time! Open a FREE Sharekhan Demat A/c in 15 mins* and continue your analysis with real-time data.

Market Data

Essential tool: analyze, trade, manage, decide.

What’s Your Call?

Collective community sentiment on Titan Biotech Ltd

Your Vote -

Buy

52.00%

Hold

20.00%

Sell

28.00%

52.00%

25 users have voted

No Records Found

Option Chain

Analyzes market sentiment, predicts Titan Biotech Ltd' movement.

NO_RECORD_FOUND

News

Media spotlight triggers stock stock attention, sentiment.

  • Titan Biotech Ltd. - Disclosure Under Regulation 7(2) Of The SEBI (Prohibition Of Insider Trading) Regulations, 2015

    2 Sep 2025, 11:18AM Disclosure under Regulation 7(2) of SEBI (Prohibition of Insider Trading) Regulation 2015 by Mr. Ravinder Gupta belonging to Promoter Group in Form-C
  • Titan Biotech Ltd. - Notice Of Thirty- Third (33Rd) Annual General Meeting

    29 Aug 2025, 1:30PM Notice of Thirty- Third(33rd) Annual General Meeting of the Company Scheduled to be held on Friday, September 26, 2025.
  • Titan Biotech Ltd. - Reg. 34 (1) Annual Report.

    29 Aug 2025, 1:18PM Annual Report of the Company for Financial Year 2024-25
  • Titan Biotech Ltd. - Revised Intimation For Book Closure Start Date

    25 Aug 2025, 11:16AM The Book Closure start date shall be 20th September, 2025 for of 33rd Annual General Meeting of the Company.
  • Titan Biotech Ltd. - Revised Intimation Of AGM Date, Record Date And Book Closure

    25 Aug 2025, 11:10AM With reference to our earlier intimation dated 13th August, 2025,We Wish to inform you that Book Closure Start date was inadvertently mentioned as 21s
  • Titan Biotech Ltd. has declared 20% Final dividend for the financial year March 2025

    16 Aug 2025, 7:00AM Titan Biotech Ltd. on Friday, 30 May 2025, has announced Final dividend of 20 percent on Equity Share, to its shareholders holding shares on the regis
  • Titan Biotech Ltd. - Fixation Of Annual General Meeting Date, Record Date, Book Closure Date And E-Voting Date

    13 Aug 2025, 5:06PM The 33rd AGM of the Company has been scheduled to be held on 26th September, 2025 through VC/OAVM and the Company accordingly fixed record date, Book
  • Titan Biotech Ltd. - Record Date For Determining Members Eligible To Receive Dividend For The Financial Year 2024-25

    13 Aug 2025, 4:57PM Record date for determining members eligible to receive dividend for the Financial Year 2024-25
  • Titan Biotech Ltd. - Announcement under Regulation 30 (LODR)-Change in Directorate

    13 Aug 2025, 4:51PM Appointment of Additional Independent Director w.e.f 13th August, 2025 & Re appointment of Managing Directors.
  • Titan Biotech Q1 net profit up 8.07% at Rs 6.16 cr

    13 Aug 2025, 4:50PM The company reported standalone net profit of Rs 6.16 crore for the quarter ended June 30, 2025 as compared to Rs 5.70 crore in the same period last y
  • Titan Biotech Ltd. - Board Meeting Outcome for Outcome Of Board Meeting Held On August 13, 2025

    13 Aug 2025, 4:31PM We are submitting outcome of Board Meeting held on August 13, 2025.
  • Titan Biotech Ltd. - Unaudited Financial Results For Quarter Ended June 2025

    13 Aug 2025, 4:24PM Unaudited Financial Results along the limited review report from the Statutory Auditor of the Company for the quarter ended June 2025
  • Titan Biotech Ltd. - Board Meeting Intimation for Consideration And Approval Of Standalone And Consolidated Financial Results

    1 Aug 2025, 6:39PM Titan Biotech Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/08/2025 ,inter alia, to consider and ap
  • Titan Biotech Ltd. - Announcement On Legal Notice Invoking Arbitration In A Disputed Matter

    25 Jul 2025, 11:27AM The legal notice invoking arbitraiton received from a private limited company supplying software upgradation services to company. The dispute is regar
  • Titan Biotech Ltd. - Announcement Regarding Receipt Of Legal Notice Invoking Arbitration In A Disputed Matter.

    24 Jul 2025, 3:25PM Notice received invoking arbitration in a disputed matter from advocate of nGenious Solutions Private Limited claiming disputed dues as per Annexure A
  • Titan Biotech Ltd. has submitted to BSE the Shareholding Pattern for the Period Ended June 30, 2025

    14 Jul 2025, 11:30AM As of June 2025, 55.87% is owned by Indian Promoters and 44.12% by Public. <p align=justify> Top five Promoters holding highest number of shares of Ti
  • Titan Biotech Ltd. - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

    5 Jul 2025, 6:01PM Certificate under Reg 74(5) of SEBI (DP) Regulation for the quarter ended on June, 2025.

Key fundamentals

Evaluate the intrinsic value of Titan Biotech Ltd stock 

Name March-25 March-24 March-23 March-22 March-21
Assets 147.2358 135.613 113.0902 92.0429 73.3559
Liabilities 147.2358 135.613 113.0902 92.0429 73.3559
Equity 8.2637 8.2637 8.2637 8.2637 8.2637
Gross Profit 25.4264 34.2814 29.5192 31.1807 41.8054
Net Profit 18.2711 23.6632 21.0248 21.6843 28.7726
Cash From Operating Activities 20.1233 21.1463 21.1783 21.9524 17.7452
NPM(%) 11.67 14.42 14.6 17.55 23.49
Revenue 156.4508 164.0721 143.9993 123.5488 122.4593
Expenses 131.0244 129.7907 114.4801 92.3681 80.6538
ROE(%) 13.28 17.19 15.28 15.76 20.91

Shareholding Pattern

Corporate Action

XD-Date Dividend-Amount Dividend-% Dividend Yield(%GE) Price on that day

Peers

Other companies within the same industry or sector that are comparable to Titan Biotech Ltd

Company Price Price (% change) pe(x) EV/EBITDA(x) ROE(%) ROCE(%)
GRM Overseas Ltd 360.75 -0.73 35.47 4248.90 499.06 0.00
Jain Irrigation Systems Ltd 51.84 -1.28 105.78 48632.91 24.37 0.00
Tierra Agrotech Ltd 41.83 -4.82 0.00 3960.85 -17.66 0.00
Kohinoor Foods Ltd 34.21 0.23 0.35 2625.22 983.91 0.00

Company Info

Titan Medicares Ltd. (hereinafter referred to as "The Company" or TML) was incorporated as a public limited company on 18th February, 1992 under the Companies Act, 1956 and obtained the certificate of Commencement of Business on 25th February, 1992 from the Registrar of Companies Delhi & Haryana at New Delhi. 2007 - The Company has recently bagged export orders more than USD 130000 for export of its products. 2010 - Titan Biotech Ltd has recommended dividend of 5% on equity shares i.e. Rs. 0.50 per share. 2014 - Titan Biotech Ltd has recommended dividend of Rs. 0.75 per equity share of Rs. 10/- each.

Titan Medicares Ltd. (hereinafter referred to as "The Company" or TML) was incorporated as a public limited company on 18th February, 1992 under the Companies Act, 1956 and obtained the certificate of Commencement of Business on 25th February, 1992 from the Registrar of Companies Delhi & Haryana at New Delhi. 2007 - The Company has recently bagged export orders more than USD 130000 for export of its products. 2010 - Titan Biotech Ltd has recommended dividend of 5% on equity shares i.e. Rs. 0.50 per share. 2014 - Titan Biotech Ltd has recommended dividend of Rs. 0.75 per equity share of Rs. 10/- each.

Read More

Parent Organisation

Titan Biotech Ltd.

Founded

18/02/1992

Managing Director

Mr.Naresh Kumar Singla

NSE Symbol

FAQ

The current price of Titan Biotech Ltd is

The 52-week high for Titan Biotech Ltd is

The market capitalization of Titan Biotech Ltd is currently This value can fluctuate based on stock price movements and changes in the number of shares outstanding.

To buy Titan Biotech Ltd shares, you need to have a brokerage account. First, choose a reputable brokerage firm, open an account, and complete the necessary KYC procedures.

To invest in Titan Biotech Ltd, you need a brokerage account. After opening an account and completing the KYC process, you can fund your account and use the trading platform to purchase Titan Biotech Ltd shares.

The CEO of Titan Biotech Ltd is Mr.Naresh Kumar Singla, who has been leading the company with a vision to expand its renewable energy portfolio and drive sustainable growth.

OPEN FREE* DEMAT ACCOUNT